Annu Rev Med. 2006;57:65-81.

Effective cancer therapy through immunomodulation.

Source

National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1374, USA. tawald@helix.nih.gov

Abstract

MAbs directed toward tumor cells, tumor neovasculature, and host negative immunoregulatory elements (checkpoints) have emerged as useful immunotherapeutic agents against cancer. However, effective active modulation of the immune response with anticancer vaccines will require identifying appropriate tumor-rejection antigens; optimizing the interactions of peptides, antigen-presenting cells, and T cells; and blockading negative immunological checkpoints that impede an effective immune response. Checkpoints being targeted include CTLA-4 and PD1 that are negative signaling receptors expressed on activated T cells, CD4+CD25+ Foxp3-expressing Tregs (suppressor T cells), IL-2-mediated activation-induced cell death (AICD), and the cytokine TGFbeta.

PMID:: 16409137; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade. [Semin Oncol. 2010]
Review Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.
Weber J. Semin Oncol. 2010 Oct; 37(5):430-9.
The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. [Int Immunol. 2007]
The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J, Rovis F, Mitchell P, Afzali B, Tsang JY, Garin M, Lechler RI, Lombardi G, Garden OA. Int Immunol. 2007 Jun; 19(6):785-99. Epub 2007 Jun 1.
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. [Int Immunol. 2007]
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS, Krishnadas DK, Agrawal B. Int Immunol. 2007 Mar; 19(3):227-37. Epub 2007 Feb 7.
Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. [PLoS Pathog. 2009]
Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M. PLoS Pathog. 2009 Aug; 5(8):e1000543. Epub 2009 Aug 14.
Review Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors. [Handb Exp Pharmacol. 2008]
Review Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA, Hu P, Epstein AL. Handb Exp Pharmacol. 2008; (181):291-328.

See reviews... See all...

Cited by 13 PubMed Central articles

The ultimate goal of curative anti-cancer therapies: inducing an adaptive anti-tumor immune response. [Front Immunol. 2011]
The ultimate goal of curative anti-cancer therapies: inducing an adaptive anti-tumor immune response.
Fridman WH, Teillaud JL, Sautès-Fridman C, Pagès F, Galon J, Zucman-Rossi J, Tartour E, Zitvogel L, Kroemer G. Front Immunol. 2011; 2:66. Epub 2011 Dec 1.
Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma. [Cell Immunol. 2011]
Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.
Mkrtichyan M, Ghochikyan A, Davtyan H, Movsesyan N, Loukinov D, Lobanenkov V, Cribbs DH, Laust AK, Nelson EL, Agadjanyan MG. Cell Immunol. 2011; 270(2):188-97. Epub 2011 May 12.
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. [Cancer Res. 2010]
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B, Wang L, Kowolik C, Deng J, Figlin R, et al. Cancer Res. 2010 Oct 1; 70(19):7455-64. Epub 2010 Sep 14.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Effective cancer therapy through immunomodulation.
Effective cancer therapy through immunomodulation.
Annu Rev Med. 2006 ;57:65-81.

PubMed
Neuropsychological functioning and sleep patterns in the elderly.
Neuropsychological functioning and sleep patterns in the elderly.
Med J Aust. 1992 Jul 6 ;157(1):51-2.

PubMed
PepHMM: a hidden Markov model based scoring function for mass spectrometry datab...
PepHMM: a hidden Markov model based scoring function for mass spectrometry database search.
Anal Chem. 2006 Jan 15 ;78(2):432-7.

PubMed
[Changes of gene expression profiles in CCl4 injured liver of mice].
[Changes of gene expression profiles in CCl4 injured liver of mice].
Yao Xue Xue Bao. 2005 Oct ;40(10):898-902.

PubMed
Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diab...
Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diabetic and nondiabetic rats.
Oncol Res. 2005 ;15(6):301-11.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Effective cancer therapy through immunomodulation.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 13 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information